Walgreens Boots Alliance Inc (NASDAQ:WBA) Shares Sold by Notis McConarty Edward

Notis McConarty Edward cut its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 4.4% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,950 shares of the pharmacy operator’s stock after selling 365 shares during the period. Notis McConarty Edward’s holdings in Walgreens Boots Alliance were worth $435,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently modified their holdings of the company. Comerica Securities Inc. grew its stake in shares of Walgreens Boots Alliance by 23.7% in the 4th quarter. Comerica Securities Inc. now owns 16,457 shares of the pharmacy operator’s stock worth $1,124,000 after acquiring an additional 3,154 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Walgreens Boots Alliance by 5.7% in the 4th quarter. Dimensional Fund Advisors LP now owns 7,374,621 shares of the pharmacy operator’s stock worth $503,913,000 after acquiring an additional 395,620 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Walgreens Boots Alliance by 7.8% in the 4th quarter. Geode Capital Management LLC now owns 11,529,136 shares of the pharmacy operator’s stock worth $786,522,000 after acquiring an additional 834,241 shares in the last quarter. Chickasaw Capital Management LLC grew its stake in shares of Walgreens Boots Alliance by 3.0% in the 1st quarter. Chickasaw Capital Management LLC now owns 26,622 shares of the pharmacy operator’s stock worth $1,684,000 after acquiring an additional 775 shares in the last quarter. Finally, Polaris Greystone Financial Group LLC bought a new stake in shares of Walgreens Boots Alliance in the 1st quarter worth $27,444,000. 62.12% of the stock is currently owned by hedge funds and other institutional investors.

Several research firms recently weighed in on WBA. Guggenheim began coverage on shares of Walgreens Boots Alliance in a research report on Thursday, April 18th. They set a “neutral” rating and a $59.00 price target for the company. JPMorgan Chase & Co. reduced their price target on shares of Walgreens Boots Alliance from $74.00 to $73.00 and set an “overweight” rating for the company in a research report on Friday, June 28th. Bank of America reduced their price target on shares of Walgreens Boots Alliance from $53.00 to $51.00 and set an “underperform” rating for the company in a research report on Monday, June 3rd. Zacks Investment Research lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and set a $53.00 price target for the company. in a research report on Monday, June 10th. Finally, BidaskClub lowered shares of Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Monday, June 24th. Six research analysts have rated the stock with a sell rating, ten have given a hold rating and four have given a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $63.82.

NASDAQ:WBA traded down $1.70 on Monday, reaching $51.98. 205,339 shares of the company’s stock were exchanged, compared to its average volume of 4,236,000. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.37 and a current ratio of 0.76. The firm has a market capitalization of $48.48 billion, a price-to-earnings ratio of 8.64, a price-to-earnings-growth ratio of 1.34 and a beta of 0.81. Walgreens Boots Alliance Inc has a 52 week low of $49.31 and a 52 week high of $86.31. The company has a fifty day moving average of $54.37.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, June 27th. The pharmacy operator reported $1.47 earnings per share for the quarter, topping analysts’ consensus estimates of $1.42 by $0.05. The firm had revenue of $34.59 billion during the quarter, compared to analyst estimates of $34.52 billion. Walgreens Boots Alliance had a net margin of 3.53% and a return on equity of 22.08%. The company’s quarterly revenue was up .7% on a year-over-year basis. During the same quarter last year, the business earned $1.53 earnings per share. On average, equities analysts predict that Walgreens Boots Alliance Inc will post 5.99 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 12th. Stockholders of record on Tuesday, August 20th will be issued a $0.458 dividend. This represents a $1.83 dividend on an annualized basis and a dividend yield of 3.52%. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. The ex-dividend date is Monday, August 19th. Walgreens Boots Alliance’s dividend payout ratio is presently 29.24%.

In other news, CAO Marco Patrick Anthony Pagni sold 20,000 shares of the stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $53.05, for a total value of $1,061,000.00. Following the sale, the chief accounting officer now directly owns 435,811 shares of the company’s stock, valued at $23,119,773.55. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 15.73% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Recommended Story: Diversification Important in Investing

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.